EVEROL

Serial Number 88930318
606

Registration Progress

Application Filed
May 22, 2020
Under Examination
Nov 17, 2020
Approved for Publication
Sep 22, 2020
Published for Opposition
Sep 22, 2020
Registered

Trademark Image

EVEROL

Basic Information

Serial Number
88930318
Filing Date
May 22, 2020
Published for Opposition
September 22, 2020
Abandonment Date
December 18, 2023
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Dec 18, 2023
Classes
005

Rights Holder

Bayer Animal Health GmbH

99
Address
Kaiser-Wilhelm-Allee 20
Leverkusen 51373
DE

Ownership History

Bayer Animal Health GmbH

Original Applicant
99
Leverkusen DE

Bayer Animal Health GmbH

Owner at Publication
99
Leverkusen DE

Legal Representation

Attorney
Aaron Sternhagen

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

45 events
Date Code Type Description Documents
Dec 18, 2023 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Dec 18, 2023 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
May 20, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 19, 2023 EX5G S SOU EXTENSION 5 GRANTED Loading...
May 19, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
May 16, 2023 EXT5 S SOU EXTENSION 5 FILED Loading...
May 16, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 16, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 14, 2022 EXT4 S SOU EXTENSION 4 FILED Loading...
Nov 14, 2022 EX4G S SOU EXTENSION 4 GRANTED Loading...
Nov 14, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 13, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 11, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
May 11, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
May 11, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 3, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
May 3, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
May 3, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
May 3, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
May 3, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Nov 19, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 17, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
Nov 17, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
Nov 17, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 11, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 7, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 7, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
May 7, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 28, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 28, 2021 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Apr 28, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 28, 2021 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Apr 28, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Nov 17, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 22, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 22, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 2, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 19, 2020 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Aug 19, 2020 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Aug 19, 2020 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Aug 19, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 19, 2020 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Aug 18, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 10, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 26, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Drug delivery agents made with microencapsulation technology, namely, delivery agents in the form of powders, tablets, and capsules that provide controlled release of the active ingredients of veterinary medicinal products

Classification

International Classes
005